Authors: Mantovani, G Maccio, A Mulas, C Massa, E Mudu, MC Massidda, S Massa, D Murgia, V Ferreli, L Astara, G Proto, E Tore, G Mura, M Amichetti, M

Citation: G. Mantovani et al., Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: Clinical outcome, toxicity and organ/function preservation, TUMORI, 87(4), 2001, pp. S43-S44

Authors: Mantovani, G Maccio, A Massa, E Mulas, C Mudu, MC Massidda, S Massa, D Murgia, V Ferreli, L Succu, G Astara, G Proto, E Tore, G Mura, M Maxia, G

Citation: G. Mantovani et al., Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: Clinical outcome, toxicity and organ/function preservation, INT J ONCOL, 16(6), 2000, pp. 1227-1233

Authors: Mantovani, G Maccio, A Massa, E Mulas, C Mudu, MC Massidda, S Massa, D Murgia, V Ferreli, L Succu, G Astara, G Proto, E Tore, G Mura, M Maxia, G

Citation: G. Mantovani et al., Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: Clinical response and organ/function preservation, ONCOL REP, 6(6), 1999, pp. 1425-1430

Authors: Mantovani, G Ghiani, M Curreli, L Maccio, A Massa, D Succu, G Lai, P Massa, E Mudu, MC Astara, G

Citation: G. Mantovani et al., Assessment of the efficacy of two dosages and schedules of human recombinant erythropoietin in the prevention and correction of cisplatin-induced anemia in cancer patients, ONCOL REP, 6(2), 1999, pp. 421-426